Prevention & Chronic Conditions

About

Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.

Articles

SGLT2 Inhibitors and HF Prevention

Published:

04 November 2019

Citation:

Cardiac Failure Review 2019;5(3):169–72.

Myocardial Mitochondrial Reactive Oxygen Species Production is Reduced in the Left Ventricle of Mechanically Unloaded Hearts

Published:

27 October 2017

Citation:

Interventional Cardiology Review 2017;12(2 Suppl 2):24-25.

Incorporating Infarct Size into Trial Composite Endpoints: Implications for Unloading Trials

Published:

11 May 2017

Citation:

Interventional Cardiology Review 2017;12(1 Suppl 1):19-21.

BiOSS® Clinical Programme – State of the Art – BiOSS LIM® Stent – The Novel Option for Coronary Bifurcation Treatment

Published:

11 May 2015

Citation:

Interventional Cardiology Review 2015;10(2 Suppl 1):1-8.